Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Warma Interview is fire!!!!
View:
Post by Gbathat on Mar 07, 2024 6:44pm

Warma Interview is fire!!!!

https://www.ceocfointerviews.com/promisneurosciences24.html

"For us specifically, I think a lot of people are excited now that we are in the clinic. Once we start getting human safety and proof-of-concept data, this interest should grow exponentially. This could be when we see a significant value inflection. Once data become available, which is expected in the near-term, we should start to unlock this potential. Over the coming months – not years – we should see some exciting data that we expect will validate our approach and create value."
Comment by G1945V on Mar 08, 2024 6:02am
The "exciting data" will be out in July 2024, the estimated Study Completion date. https://classic.clinicaltrials.gov/ct2/show/NCT06105528 G1945V
Comment by M101 on Mar 08, 2024 12:07pm
Upbeat maybe, but fire?  What I read still says "don't rock the boat".  I think we'd get more respect and media coverage if the line was "this sector needs to have its butt kicked, and we've got the boot"  "These are companies that we see very much as partners. We are not looking to compete with these large companies. Rather, we are ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities